[ 메디채널 김갑성 기자 ] ISGlobal, supported by Rockefeller Foundation, analyzed impact of severe global aid cuts in 93 countries, with 21 in Asia New study published in The Lancet finds slashing global aid, particularly by US and European countries, will reverse decades of progress in fighting diseases BANGKOK, Feb. 3, 2026 -- The Lancet Global Health published a new peer-reviewed study today by the Barcelona Institute for Global Health (ISGlobal), which warns that a precipitous drop in global aid could lead to 22.6 million additional deaths by 2030 across 93 low- and middle- income coun
ZEISS ARTEVO 750 and ZEISS ARTEVO 850 surgical microscopes provide ophthalmic surgeons in China with end-to-end workflow integration to improve efficiency, precision, and surgical safety. JENA, Germany and SHANGHAI, Feb. 3, 2026 -- ZEISS Medical Technology announced today that China's National Medical Products Administration (NMPA) has approved the ZEISS ARTEVO 750 and ARTEVO 850 ophthalmic microscopes. The microscopes provide high quality optical and digital visualization for both anterior and posterior segments. With upgrades spanning both hardware and software, the newly app
SAN FRANCISCO, Feb. 2, 2026 -- On January 11, as the global healthcare industry gathered in San Francisco, the BIOSeedin Winter Innovation Partnering Summit successfully convened ahead of J.P. Morgan 2026. ACROBiosystems, as a key strategic partner, joined hands with multiple enterprises to participate in the event. Hosted by bioSeedin and centered on the theme "Global Matching of Innovative Assets," the summit brought together multinational pharmaceuticals, investors, and emerging biotech companies to explore licensing opportunities and globalization strategies for innovativ
COPENHAGEN, Denmark, Feb. 2, 2026 -- 3Shape today announced that the TRIOS 6 intraoral scanner has been honored with the European Product Design Award (EPDA) 2025 in the category Industrial/Healthcare: Medical Products. The EPDA Award Statement: "TRIOS 6 combines cutting-edge functionality with meticulous Danish design. Its sleek, pen-grip form reflects the precision of its advanced technology while ensuring effortless ergonomics. The new blue metallic finish introduces a fresh and modern aesthetic, and a level of design rarely seen in dental equipment. Complementing this is its a
[ 메디채널 김갑성 기자 ] - SanegeneBio grants exclusive worldwide license to one of its RNAi programs to Genentech - SanegeneBio to receive $200 million upfront payment and will be eligible to receive development and commercialization milestone payments, totaling up to $1.5 billion, plus tiered royalties - Genentech will be responsible for the subsequent clinical development and commercialization globally BOSTON, SHANGHAI and SUZHOU, China, Feb. 2, 2026 -- SanegeneBio, a clinical-stage biotechnology company developing innovative RNAi therapeutics, today announced a global licens
[ 메디채널 김갑성 기자 ] Alliance to Enhance Shonan Beauty Clinic Brand Recognition in China and Support Growth in Inbound Medical Demand to Japan IRVINE, Calif., Feb. 2, 2026 -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ("SBC Medical" or the "Company"), a global provider of comprehensive consulting and management services to medical corporations and their clinics, today announced that Medical Corporation Nasukai, a Japan-based medical corporation supported by SBC Medical and the operator of Shonan Beauty Clinic, has entered into a strategic business alliance w
[ 메디채널 김갑성 기자 ] Strategic expansion positions Singapore as a strategic arm for healthcare logistics in the APAC region. DHL Group invests €10 million in a new pharmaceutical hub in Singapore to enhance international logistics and healthcare logistics infrastructure across the Asia-Pacific region. The expansion bolsters specialised services for shipping medicinal products, clinical trials, and medical devices via DHL Medical Express and a dedicated medical courier framework. This initiative contributes to a €500 million regional investment in health logistics by 2030, addressing
The National Comprehensive Cancer Network (NCCN) is collaborating with the Vietnam National Cancer Hospital (K Hospital) to adapt regional recommendations for treating breast and ovarian cancers. HANOI, Vietnam, Feb. 2, 2026 -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—is marking a major milestone in work to improve outcomes for people with cancer across Vietnam, in collaboration with the Vietnam National Cancer Hospital (K Hospital). The organizations have now published NCCN Clinical Practice Guideline
[ 메디채널 김갑성 기자 ] The new technology is the world's smallest, catheter-delivered defibrillation lead AUSTIN, Texas, Feb. 2, 2026 -- Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently became the first in the nation to implant an FDA-approved novel defibrillation lead—a specialized, insulated wire that connects to an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT-Ds) device to the heart and corrects abnormal rhythm. The defibrillation lead is the world's smallest, catheter-delivered defibril
미국종합암네트워크, 베트남 국립암병원과 협력해 유방암 및 난소암 치료 위한 지역 맞춤형 권고안 마련 하노이, 베트남, 2026년 2월 2일 -- 미국의 주요 암 치료 기관 연합체인 미국 종합암네트워크(National Comprehensive Cancer Network®, NCCN®)가 베트남 국립암병원(Vietnam National Cancer Hospital, K Hospital)과 협력해 베트남 전역의 암 환자 치료 성과를 개선하기 위한 노력에서 중요한 이정표를 세우는 중이다. 양 기관은 유방암과 난소암을 대상으로 한 베트남 전용 NCCN 종양학 임상실무지침(NCCN Clinical Practice Guidelines in Oncology®, NCCN Guidelines®)을 공식 발표했으며 이는 베트남 여성에서 발생률이 높은 암종에 대응하고, 전반적인 진료의 질을 향상하며 역내에서 베트남의 역할을 강화하겠다는 의지를 보여준다. 지역별 실무 관행, 규제 상태, 의료 기술 수준을 반영해 맞춤화된 NCCN 지침 해외 번안®(International Adaptations of the